Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System.
Charleston Ribeiro PintoLindemberg Assunção CostaAntônio Carlos Moreira LemosEduardo Martins NettoPublished in: Einstein (Sao Paulo, Brazil) (2020)